Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 13Glioblastoma 10Glioma 7Astrocytoma 6Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Neoplasms 4Brain Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Stomach Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Oligodendroglioma 2Melanoma 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Seroma 1Rectal Neoplasms 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Patient Preference 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1

Interventions

Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Seroma × Surgical Procedures, Operative × Clear all
NCT00161980 2006-10-23

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Baxter Healthcare Corporation

Phase 3 Completed
Breast

Breast Neoplasms, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡